Figure 1 - uploaded by Thomas Haaf
Content may be subject to copyright.
Profile and facial view of the t(1;6) translocation patient at the age of eight years. Written permission was obtained from the child’s parents for these images to be reproduced. 

Profile and facial view of the t(1;6) translocation patient at the age of eight years. Written permission was obtained from the child’s parents for these images to be reproduced. 

Source publication
Article
Full-text available
A boy with developmental delay, particularly of speech, a distinct face, antineutrophil cytoplasmic antibodies, and recurrent infections was found to have an apparently balanced de novo t(1;6)(q32.3;q22.3) translocation. Fluorescent in situ hybridisation with BAC/PAC clones and long range polymerase chain reaction products assessed in the human gen...

Context in source publication

Context 1
... novo balanced chromosome rearrangements that disrupt or otherwise inactivate genes in the breakpoint regions can cause mental retardation or congenital malformations or both. 1–3 The cytogenetic and molecular characterisation of disease associated balanced chromosome rearrangements offers a successful instrument for identifying genes involved in inherited disease. Over the past decade, well over 100 genetic loci and genes of Mendelian disorders have been found by such positional cloning approaches. 4 5 Here we describe our analysis of a de novo t(1;6)(q32.3;q22.3) translocation in a dysmorphic and devel- opmentally delayed boy with an early childhood history of recurrent chest infections. The constitutional chromosome breakpoint on chromosome 6q22 is of particular interest, because it coincides with a common breakpoint cluster region in T cell malignancies. The TCBA1 gene is thought to be a target gene for the tumour specific chromosome rearrangements; however, its function remains to be elucidated. 6 Our patient provides important clues as to the phenotypic effects of constitutional TCBA1 haploinsufficiency. The patient, a boy, was clinically assessed by one of us (DTP) and recruited to the study with parental consent. He was the oldest child of healthy non-consanguineous parents. There was no history of miscarriages. He was born at 38 weeks’ gestation. His birth weight was on the 50th centile, and his occipito-frontal head circumference (OFC) was between the 75th and 91st centiles. He was found to have an atrioven- tricular septal defect, which closed spontaneously in the first few months of life, and a slightly dysplastic pulmonary valve. Macrocephaly was also noted and thought to be familial, with a paternal OFC of 5 cm above the 99.6th centile, and maternal OFC on the 91st centile. He had bilateral orchidopexies for undescended testes, and a fundoplication for marked gastro-oesophageal reflux. Other problems included recurrent chest infections, which had improved, asthma, and enuresis. His development was delayed, and formal assessment at 17 months showed a mental age of 12.3 months (GQ = 78). He had general learning difficulties, especially in the area of expressive speech. When assessed at the age of five years, his height was on the 25th centile, weight on the 75th centile, and OFC between the 75th and 91st centiles. He was very fair skinned and had very blond, almost white hair, although both his parents had darkish hair. He was hyperteloric, and had blue eyes and small palpebral fissures. He also had prominent corneal nerves. His nose was prominent and he had a thin, tented upper lip. He had fetal finger pads, overlapping third and fifth toes, very hyperextensible joints, and a slightly hirsute back. On follow up at the age of eight years his facial features had coarsened and his hair had become darker (fig 1). He had also been extensively investigated for frequent loose stools, for which so far no cause had been found. He continued to have difficulties with his motor skills, and communication, particularly in the area of expressive speech. Investigations have included cranial magnetic resonance imaging, which showed some enlargement of lateral and third ventricles with no evidence of aqueduct stenosis. A renal ultrasound, EEG, thyroid function test, sweat test, and lysosomal enzyme screen were normal. Immunological studies did not show any specific abnormalities of the lymphocyte subpopulations or of immunoglobulin and anti- body production. However, he was found to have raised antineutrophil cytoplasmic antibodies of the cytoplasmic pattern (C-ANCA), which are often associated with vasculitides. BAC and PAC clones were selected from the Wellcome Trust Sanger Institute ensembl contigs () and obtained from the resource centre primary database of the German Human Genome Project (). In order to amplify larger (approximately 10 kb) BAC/PAC subfragments, the Expand Long Template polymerase chain reaction (PCR) system (Roche Products, Basel, Switzerland) was used according to the recommendations of the manu- facturer, with a series of primer pairs (table 1) chosen from the genomic sequence of breakpoint spanning clones. Genomic BAC/PAC DNAs and their long range PCR products were labelled with biotin-16-dUTP or digoxigenin-11-dUTP (Roche) by standard nick translation. Fluorescence in situ hybridisation (FISH) was carried out on metaphase spreads from EBV transformed lymphoblastoid cells using standard molecular cytogenetic techniques. 3 Total RNA was extracted from mouse tissues or whole embryos with Trizol reagent (Invitrogen, San Diego, California, USA) and reversely transcribed using Superscript III reverse transcriptase (Invitrogen). cDNA was synthesised from 3 m g of total RNA at 55 ̊ C with mouse Tcba1 reverse transcription primer (5 9 -cgattcgcagagacttaga-3 9 ); 2 m l of this cDNA were then used as template in a PCR reaction with mouse Tcba1 forward (5 9 -atgggttattgcagtggca-3 9 ) and reverse primers. PCR was carried out with an initial denaturation at 94 ̊ C for three minutes, 30 cycles of 94 ̊ C for 45 seconds, 56 ̊ C for 45 seconds, 72 ̊ C for 1.5 minutes, and a final 10 minute extension at 72 ̊ C. To obtain the full length cDNA sequence, rapid amplification of cDNA ends (RACE) was done with the SMART RACE cDNA amplification kit (Clontech, Palo Alto, California, USA), according to the manufacturer’s instruc- tions. Briefly, 5 9 -RACE PCR was undertaken with a Tcba1 specific primer (5 9 -agcgatggtcttctggagcccagtctgg-3 9 ) and Universal Primer A mix from the kit. 3 9 -RACE was done with another gene specific primer (5 9 -gtcccccagtcacatcctt- taggcgaacac-3 9 ) and Universal Primer A mix. PCR was carried out with five cycles of 94 ̊ C for 30 seconds, 72 ̊ C for three minutes, five cycles of 94 ̊ C for 30 seconds, 70 ̊ C for 30 seconds, 72 ̊ C for three minutes, and 25 cycles of 94 ̊ C for 30 seconds, 68 ̊ C for 30 seconds, 72 ̊ C for three minutes, with a final 10 minute extension at 72 ̊ C. The PCR products were cloned into pCR2.1-TOPO vector (Invitrogen) and sequenced. DNA sequence analysis was done using the genome BLAST program ( Amino acid sequence alignment and transmembrane helix prediction were performed using the TmHMM and Clustal programs of Heidelberg Unix Sequence Analysis Resources (HUSAR) (). Chromosome banding analysis of this patient revealed an apparently balanced reciprocal translocation involving the exchange of material between the long arms of chromosomes 1 and 6 (fig 2A). The parental karyotypes were normal. In order to map the de novo translocation breakpoints at higher DNA resolution, we have assembled BAC/PAC contigs of the critical chromosome regions 1q32.3 and 6q22.3 according to the database (fig 2D). Individual BAC/PACs from the breakpoint regions were co-hybridised with chromosome 1pter and 6pter identification probes to the patient’s metaphase spreads. BAC RP11-338C15 at 209.4 Mb on chromosome 1 and PAC RP1-157N22 at 124.6 Mb on chromosome 6 produced FISH signals on the normal chromosome 1 and 6, respectively, and on both derivative chromosomes (data not shown), as expected for breakpoint spanning clones. To narrow down the breakpoint regions further, three long range PCR products—338C15A, 338C15B, 338C15D—were generated from the chromosome 1 breakpoint BAC and five PCR products—157N22A, B, C, D, and E—from the chromosome 6 breakpoint PAC (table 1). The 9.8 kb BAC fragment 338C15D produced a split hybridisation signal on the derivative chromosomes (fig 2B) and therefore must contain the 1q32.3 breakpoint. Similarly, the 6q22.3 breakpoint was localised to the 12.8 kb PAC fragment 157N22E, which hybridised to the normal chromosome 6 and both derivative chromosomes (fig 2C). According to our high resolution FISH mapping results the translocation breakpoint ...

Citations

... Neurotransmitters play a significant role in regulating reproductive functions, such as the modulation of the gonadotropin-releasing hormone (GnRH) and other hormones controlling the reproductive cycle. Previous studies have confirmed that germline alterations in the TCBA1 gene were associated with developmental delay and typical physiological features (Yue et al., 2006). Therefore, we speculated that NKAIN2's involvement in these processes might confer advantages in terms of fitness and reproductive success, leading to its strong selection in the population and potential association with litter traits. ...
Article
Full-text available
The litter trait is one of the most important economic traits, and increasing litter size is of great economic value in the pig industry. However, the molecular mechanisms underlying pig litter traits remain elusive. To identify molecular markers and candidate genes for pig litter traits, a genome-wide association study (GWAS) and selection signature analysis were conducted in a Yorkshire pig population. A total of 518 producing sows were genotyped with Illumina Porcine SNP 50 BeadChip, and 1969 farrowing records for the total number born (TNB), the number born alive (NBA), piglets born dead (PBD), and litter weight born alive (LWB) were collected. Then, a GWAS was performed for the four litter traits using a repeatability model. Based on the estimated breeding values (EBVs) of TNB, 15 high- and 15 low-prolificacy individuals were selected from the 518 sows to implement selection signature analysis. Subsequently, the selection signatures affecting the litter traits of sows were detected by using two methods including the fixation index (FST) and θπ. Combining the results of the GWAS and selection signature analysis, 20 promising candidate genes (NKAIN2, IGF1R, KISS1R, TYRO3, SPINT1, ADGRF5, APC2, PTBP1, CLCN3, CBR4, HPF1, FAM174A, SCP2, CLIC1, ZFYVE9, SPATA33, KIF5C, EPC2, GABRA2, and GABRA4) were identified. These findings provide novel insights into the genetic basis of pig litter traits and will be helpful for improving the reproductive performances of sows in pig breeding.
... Paracentric inversion with deletion Pericentric inversion with deletion 3-Way complex translocation The prime pathogenic mechanism of a CCR is disruption of the genomic architecture either within a gene or between a gene and its regulatory elements [Yue et al., 2006;Klopocki and Mundlos, 2011]. If a CNV is associated with a CCR, haploinsufficiency or triplosufficiency of one or several genes may become an additional pathogenic mechanism [Yue et al., 2005;Poot et al., 2011a]. ...
Article
Complex chromosome rearrangements (CCRs) are currently defined as structural genome variations that involve more than 2 chromosome breaks and result in exchanges of chromosomal segments. They are thought to be extremely rare, but their detection rate is rising because of improvements in molecular cytogenetic technology. Their population frequency is also underestimated, since many CCRs may not elicit a phenotypic effect. CCRs may be the result of fork stalling and template switching, microhomology-mediated break-induced repair, breakage-fusion-bridge cycles, or chromothripsis. Patients with chromosomal instability syndromes show elevated rates of CCRs due to impaired DNA double-strand break responses during meiosis. Therefore, the putative functions of the proteins encoded by ATM, BLM, WRN, ATR, MRE11, NBS1, and RAD51 in preventing CCRs are discussed. CCRs may exert a pathogenic effect by either (1) gene dosage-dependent mechanisms, e.g. haploinsufficiency, (2) mechanisms based on disruption of the genomic architecture, such that genes, parts of genes or regulatory elements are truncated, fused or relocated and thus their interactions disturbed - these mechanisms will predominantly affect gene expression - or (3) mixed mutation mechanisms in which a CCR on one chromosome is combined with a different type of mutation on the other chromosome. Such inferred mechanisms of pathogenicity need corroboration by mRNA sequencing. Also, future studies with in vitro models, such as inducible pluripotent stem cells from patients with CCRs, and transgenic model organisms should substantiate current inferences regarding putative pathogenic effects of CCRs. The ramifications of the growing body of information on CCRs for clinical and experimental genetics and future treatment modalities are briefly illustrated with 2 cases, one of which suggests KDM4C(JMJD2C) as a novel candidate gene for mental retardation.
... Paracentric inversion with deletion Pericentric inversion with deletion 3-Way complex translocation The prime pathogenic mechanism of a CCR is disruption of the genomic architecture either within a gene or between a gene and its regulatory elements [Yue et al., 2006;Klopocki and Mundlos, 2011]. If a CNV is associated with a CCR, haploinsufficiency or triplosufficiency of one or several genes may become an additional pathogenic mechanism [Yue et al., 2005;Poot et al., 2011a]. ...
... As mentioned above, NKAIN2 is located within the 6q commonly deleted region in human cancers, thus reducing expression by loss of genomic copies and potentially causing haploid insufficiency. In addition, chromosome translocations affecting NKAIN2 genomic region can also lead to loss of function of this gene, both in developmental diseases and human malignancies [26,28,35]. ...
... and t(2;6)(q24.3;q22.31) with breakpoint at NKAIN2 have been reported in developmental delay [35] and neurological disorders [28] respectively, and in both cases, the consequence is constitutional inactivation of the NKAIN2 gene. ...
... NKAIN2 is transcribed in different splice variants and abundantly expressed in the brain tissues [27]. Several studies have suggested that NKAIN2 is highly specific to the central nervous system and is necessary for nervous system health and development [28,35,[42][43][44]. Bocciardi [35]. ...
Article
Objective The deletion of chromosomal region 6q was commonly found in several types of human cancers, although the tumour suppressor genes (TSGs) located within this genomic region are not well established. Our recent work detected recurrent chromosomal truncation at the Na+/K+ transporting ATPase interacting 2 (NKAIN2) gene, which was also found to be truncated in leukemia and lymphoma, suggesting that NKAIN2 is potentially one of the TSGs located in the 6q commonly deleted region in human cancers. Further genetic and cellular functional are required to confirm its tumour suppressor role. Methods We review the basic structure and biological function of NKAIN2 by published articles to find out existing evidence to support its role in tumorigenesis, emphasizing its role in prostate cancer. Results NKAIN2 gene consists of eight coding exons that span approximately 1 Mb of genomic DNA on chromosome 6q and there are four main splice variants. The function of this gene is not well investigated and the limited knowledge of this gene pointed to nervous system development. The chromosomal translocations in nervous development disorders usually lead to inactivation of this gene. In human tumours, both chromosomal deletion and translocation may also inactivate this gene and consequently contribute to tumorigenesis. Conclusions We speculate that NKAIN2 could be a novel tumor suppressor on the 6q commonly deleted chromosomal region in human cancer and propose further researches required to investigate its potential tumor suppresser role. With the deepening of its involvement in human cancer and its cellular function, the role of NKAIN2 in tumorigenesis will be uncovered, which may impact the treatment of human malignancy.
... Paracentric inversion with deletion Pericentric inversion with deletion 3-Way complex translocation The prime pathogenic mechanism of a CCR is disruption of the genomic architecture either within a gene or between a gene and its regulatory elements [Yue et al., 2006;Klopocki and Mundlos, 2011]. If a CNV is associated with a CCR, haploinsufficiency or triplosufficiency of one or several genes may become an additional pathogenic mechanism [Yue et al., 2005;Poot et al., 2011a]. ...
Article
Full-text available
Complex chromosome rearrangements (CCRs) are currently defined as structural genome variations that involve more than 2 chromosome breaks and result in exchanges of chromosomal segments. They are thought to be extremely rare, but their detection rate is rising because of improvements in molecular cytogenetic technology. Their population frequency is also underestimated, since many CCRs may not elicit a phenotypic effect. CCRs may be the result of fork stalling and template switching, microhomology-mediated break-induced repair, breakage-fusion-bridge cycles, or chromothripsis. Patients with chromosomal instability syndromes show elevated rates of CCRs due to impaired DNA double-strand break responses during meiosis. Therefore, the putative functions of the proteins encoded by ATM , BLM , WRN , ATR , MRE11 , NBS1 , and RAD51 in preventing CCRs are discussed. CCRs may exert a pathogenic effect by either (1) gene dosage-dependent mechanisms, e.g. haploinsufficiency, (2) mechanisms based on disruption of the genomic architecture, such that genes, parts of genes or regulatory elements are truncated, fused or relocated and thus their interactions disturbed – these mechanisms will predominantly affect gene expression – or (3) mixed mutation mechanisms in which a CCR on one chromosome is combined with a different type of mutation on the other chromosome. Such inferred mechanisms of pathogenicity need corroboration by mRNA sequencing. Also, future studies with in vitro models, such as inducible pluripotent stem cells from patients with CCRs, and transgenic model organisms should substantiate current inferences regarding putative pathogenic effects of CCRs. The ramifications of the growing body of information on CCRs for clinical and experimental genetics and future treatment modalities are briefly illustrated with 2 cases, one of which suggests KDM4C (JMJD2C) as a novel candidate gene for mental retardation.
... NKAIN2 (Na+/K+ Transporting ATPase-interacting 2; OMIM No. 609758) is a transmembrane protein that interacts with the beta subunit of a sodium/potassium-transporting ATPase. Truncation of NKAIN2 has been described in patients with developmental delay [13] and complex neurological impairment [14]. The interstitial duplication detected in the present case could have been inherited from either of the parents. ...
... The resulting karyotype associated with array-CGH analysis can be described as 47,XY,+ der (10)t(6;10)(6qter → 6q23. 25.0 % (log2 ratio: 0.14). The mosaicism rate found with array-CGH analysis was similar to that found with karyotyping. ...
... region revealed more than 150 genes including TCBA1, BMIQ3 and ENPP1 genes. Two balanced translocations showed that the TCBA1 (NKAIN2; Na+/K+ transporting ATPase-Interacting Protein 2) gene was truncated in 1 patient with a severe neurological phenotype (epileptic encephalopathy with spastic tetraparesis and severe psychomotor retardation, microcephaly, hand dysmorphism and hypogonadism with micropenis and cryptorchidism), and a second patient with developmental delay and recurrent infections [24,25]. These two de novo translocations provide evidence that constitutional inactivation (haploinsufficiency) of the TCBA1 gene causes developmental delay and a distinct phenotype. ...
Article
Full-text available
Prader-Willi syndrome (PWS) is characterized by hypotonia, delayed neuropsychomotor development, overeating, obesity and mental deficiency. This phenotype is encountered in other conditions, defining Prader-Willi-like syndrome (PWLS). We report a 14-year-old boy with a complex small supernumerary marker chromosome (sSMC) associated with PWLS. The propositus presents clinical features commonly found in patients with PWLS, including growth hormone deficit. Banding karyotype analysis and fluorescence in situ hybridization (FISH) revealed a marker derived from chromosome 6 and a neocentromere as suspected, but array-CGH enabled us to characterize this marker as a der(10)t(6;10)(6qter → 6q23.3::10p11.1 → 10p11.21)dn. As far as we know, this is the first diagnosed case of PWLS associated with a complex sSMC, involving a 30.9 Mb gain in the 6q16.3q23.3 region and a 3.5 Mb gain in the 10p11.21p11.1 region. Several genes have been mapped to the 6q region including the TCBA1 gene, which is associated with developmental delay and recurrent infections, the ENPP1 gene, associated with insulin resistance and susceptibility to obesity and the BMIQ3 gene, associated with body mass index (BMI). No OMIM gene was found in the smallest 10p11.21p11.1 region. We suggest that the duplicated chromosome segment 6q16.3q23.3 may be responsible for the phenotype of our case and may also be a candidate locus of PWLS.
... NKAIN2 (Na+/K+ Transporting ATPase-interacting 2; OMIM No. 609758) is a transmembrane protein that interacts with the beta subunit of a sodium/potassium-transporting ATPase. Truncation of NKAIN2 has been described in patients with developmental delay [13] and complex neurological impairment [14]. The interstitial duplication detected in the present case could have been inherited from either of the parents. ...
Article
Full-text available
‘Pure’ interstitial duplication of chr6q is rare. The varying size of duplication encompassing 6q22.31 is associated with the expressivity of dysmorphism and autism. Here, we report a unique case with facial dysmorphism, developmental delay, complex neurological impairment and spasticity unrelated to autism. Genetic analysis by aCGH exhibited a 627–971 kb dup(6)(q22.31q22.31) encompassing TRDN and NKAIN2 genes. The presence of the duplication was confirmed by quantitative PCR in the proband and phenotypically normal parents. With the current techniques, we cannot exclude presence of a deleterious homozygous point mutation in the proband where each copy would have been inherited from both parents.
... and t(2;6)(q24.3;q22.31), which resulted in constitutional inactivation of NKAIN2, but they were detected in patients with developmental delay [17] and neurological disorders [18] rather than with malignancy. ...
Article
Full-text available
Recurrent chromosome breakpoints at 6q22.31, leading to truncation and potential loss-of-function of the NKAIN2 gene, in Chinese prostate cancer patients were previously identified. In this study we investigated genomic, methylation and expression changes of NKAIN2 in a large number of prostate cancer samples and determined its functional role in prostate cancer cells. Fluorescence in situ hybridization analysis confirmed that NKAIN2 truncation is specific to Chinese while deletion of the gene is frequent in both Chinese and UK prostate cancers. Significantly reduced expression of NKAIN2 was also detected at both RNA and protein levels. Somatic mutations of NKAIN2 in prostate cancer samples exist but at very low frequency, suggesting that it is a putative tumor suppressor gene (TSG) with haploid insufficiency. Our functional studies showed that overexpression of NKAIN2 in prostate cancer cells inhibits cellular growth by promoting cell apoptosis, and decreasing cell migration and invasion. Conversely, knockdown of NKAIN2 promotes prostate cancer cell growth by inhibiting cell apoptosis, and increasing cell migration and invasion. These data imply that NKAIN2 is a novel TSG whose activity is commonly reduced in prostate cancer. It may restrain the disease development and progression by inducing apoptosis and suppressing cancer cell growth, migration and invasion. This study provides new insights into prostate carcinogenesis and opportunities for development of novel therapies for prostate cancer.
... N TCBA1 is well conserved among mammalian species. The human ortholog is expressed exclusively in brain and thymus [43]. SNPs in and around TCBA1 are linked to neurological phenotypes [44] and are associated with developmental delay [43]. ...
... The human ortholog is expressed exclusively in brain and thymus [43]. SNPs in and around TCBA1 are linked to neurological phenotypes [44] and are associated with developmental delay [43]. TCBA1 covaries remarkably well with APP in forebrain of mouse and human (r = 0.75 and r = 0.65). ...
Article
Full-text available
What proportion of genes with intense and selective expression in specific tissues, cells, or systems are still almost completely uncharacterized with respect to biological function? In what ways do these functionally enigmatic genes differ from well-studied genes? To address these two questions, we devised a computational approach that defines so-called ignoromes. As proof of principle, we extracted and analyzed a large subset of genes with intense and selective expression in brain. We find that publications associated with this set are highly skewed-the top 5% of genes absorb 70% of the relevant literature. In contrast, approximately 20% of genes have essentially no neuroscience literature. Analysis of the ignorome over the past decade demonstrates that it is stubbornly persistent, and the rapid expansion of the neuroscience literature has not had the expected effect on numbers of these genes. Surprisingly, ignorome genes do not differ from well-studied genes in terms of connectivity in coexpression networks. Nor do they differ with respect to numbers of orthologs, paralogs, or protein domains. The major distinguishing characteristic between these sets of genes is date of discovery, early discovery being associated with greater research momentum-a genomic bandwagon effect. Finally we ask to what extent massive genomic, imaging, and phenotype data sets can be used to provide high-throughput functional annotation for an entire ignorome. In a majority of cases we have been able to extract and add significant information for these neglected genes. In several cases-ELMOD1, TMEM88B, and DZANK1-we have exploited sequence polymorphisms, large phenome data sets, and reverse genetic methods to evaluate the function of ignorome genes.